GRFS (Grifols) Price-to-Operating-Cash-Flow : (As of Jul. 17, 2025)

View and export this data going back to 2011. Start your Free Trial

What is Grifols Price-to-Operating-Cash-Flow?

As of today (2025-07-17), Grifols's share price is $10.06. Grifols's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00. Hence, Grifols's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Grifols's Price-to-Operating-Cash-Flow or its related term are showing as below:

GRFS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.99 Med: 21.58 Max: 41.7
Current: 8.99

During the past 13 years, Grifols's highest Price-to-Operating-Cash-Flow Ratio was 41.70. The lowest was 8.99. And the median was 21.58.

GRFS's Price-to-Operating-Cash-Flow is ranked better than
77.52% of 685 companies
in the Drug Manufacturers industry
Industry Median: 18.87 vs GRFS: 8.99

Grifols's Cash Flow from Operations per share for the three months ended in Dec. 2024 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Grifols was 312.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 14.80% per year.

During the past 13 years, Grifols's highest 3-Year average Operating Cash Flow per Share Growth Rate was 67.90% per year. The lowest was -41.60% per year. And the median was 11.60% per year.

Grifols Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Grifols's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Price-to-Operating-Cash-Flow Chart

Grifols Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

14.74

19.26

48.00

6.89

Grifols Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	48.00	-	-	6.89

Competitive Comparison of Grifols's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - General subindustry, Grifols's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grifols's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Grifols's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Grifols Price-to-Operating-Cash-Flow Calculation

Grifols's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	10.06	/	0
	=

Grifols's Share Price of today is $10.06.
Grifols's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Grifols Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Grifols's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Grifols Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (NAS:GRFS) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

GIKLY:USA GIFLF:USA 1GRF:Italy GRFe:UK GRFPe:UK 0RDV:UK 0RDU:UK GRF.P:Spain GRF:Spain G0F0:Germany G0F0:Germany OZTA:Germany OZTA:Germany G0FB:Germany GRF:Austria

Address

Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174

Website

https://www.grifols.com

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.